NUVL Competitors & Alternatives
Compare Nuvalent Inc with similar stocks in the same industry
Biotechnology
NUVL
Main Stock$123.96
Tradestie Score
44
Market Cap
$5.95B
Analyst Upside
+0.9%
Top Competitors
218 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ROIV
Roivant Sciences Ltd. Common Shares
|
$37.45
|
$10.76B | - | 54 | Compare |
|
MRNA
Moderna, Inc. Common Stock
|
$202.63
|
$10.74B | - | 35 | Compare |
|
BMRN
BioMarin Pharmaceuticals Inc
|
$56.63
|
$10.53B | 149.2 | 67 | Compare |
|
IONS
Ionis Pharmaceuticals, Inc. Common Stock
|
$43.91
|
$10.49B | - | 58 | Compare |
|
BBIO
BridgeBio Pharma, Inc. Common Stock
|
$68.12
|
$10.22B | - | 58 | Compare |
|
MDGL
Madrigal Pharmaceuticals, Inc. Common Stock
|
$453.34
|
$10.01B | - | 62 | Compare |
|
TECH
Bio-Techne Corp.
|
$72.62
|
$9.33B | 62.6 | 61 | Compare |
|
CORT
Corcept Therapeutics Inc.
|
$107.50
|
$8.88B | 258.4 | 49 | Compare |
|
HALO
Halozyme Therapeutics, Inc.
|
$124.54
|
$8.77B | 36.5 | 36 | Compare |
|
RVMD
Revolution Medicines, Inc. Common Stock
|
$187.69
|
$8.57B | - | 57 | Compare |
More NUVL Analysis
Data updated: Oct 23, 2026 | Industry: Biotechnology (SIC 2834)
218 stocks in this industry